This site is intended for healthcare professionals
Login | Register (NOW FREE)

Medical search

haemodialysis

FREE subscriptions for doctors and students... click here
You have 3 open access pages.

Haemodialysis is the most common treatment for end-stage renal failure. Blood is shunted through an extracorporeal circulation in which waste products and excess fluid are removed by the physical processes of diffusion and ultrafiltration.

Notes:

  • home haemodialysis (HD) has the best patient outcomes (1,2) and is the most cost-effective of any dialysis modality, but its use has been declining in many countries
    • prevalence of home HD varies from 0 to 58.4 per million population, and varies between countries, more than any other renal replacement therapy (RRT) modality
    • variation cannot be explained by the variation in the use of other RRT modalities, nor by prevalence of diabetic nephropathy, national wealth or population density

  • according to the 19th annual report by the UK Renal Registry (2016), on 31 December 2015 there were 61,256 adults in the UK receiving RRT

    • of these, 53.1% had received a transplant, 41.0% were receiving haemodialysis (21.2% in satellite units, 17.8% in hospitals, 2.0% at home), 2.5% were receiving continuous ambulatory peritoneal dialysis and 3.4% were receiving automated peritoneal dialysis
    • in addition, 769 children and young people under the age of 16 years were receiving RRT
      • most had received a transplant (41% live, 34% deceased), with 13% on haemodialysis and 12% on peritoneal dialysis
    • median age of all people newly requiring RRT was 59.0 years; 22.7% of people were from minority ethnic groups

Reference:

  1. MacGregor MS et al. Home haemodialysis-international trends and variation. Nephrol Dial Transplant. 2006 Jul;21(7):1934-45.
  2. Mowatt G et al. Systematic review of the effectiveness of home versus hospital or satellite unit hemodialysis for people with end-stage renal failure. Int J Technol Assess Health Care. 2004 Summer;20(3):258-68
  3. NICE (October 2018). Renal replacement therapy and conservative management

Links:

The information provided herein should not be used for diagnosis or treatment of any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions. Copyright 2016 Oxbridge Solutions LtdĀ®. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions LtdĀ® receives funding from advertising but maintains editorial independence. GPnotebook stores small data files on your computer called cookies so that we can recognise you and provide you with the best service. If you do not want to receive cookies please do not use GPnotebook.